Spis treści:
4. PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ
| KOMISJA NADZORU FINANSOWEGO | ||||||||||||
| Raport bieżący nr | 7 | / | 2020 | |||||||||
| Data sporządzenia: | 2020-02-18 | |||||||||||
| Skrócona nazwa emitenta | ||||||||||||
| MILESTONE MEDICAL | ||||||||||||
| Temat | ||||||||||||
| Receiving CE Mark approval of pre-assembled disposable kit for CompuFlo® Epidural System in Europe | ||||||||||||
| Podstawa prawna | ||||||||||||
| Art. 17 ust. 1 MAR - informacje poufne. | ||||||||||||
| Treść raportu: | ||||||||||||
| The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company”, “the Issuer”), today announced that the new pre-assembled disposable kit for the CompuFlo® Epidural System has received CE Mark approval in Europe through the Company’s supplier. The Board of Directors of the Issuer believes that this CE Mark approval overcomes an important hurdle to commercialization in Europe. Based on market feedback, it was evident that anesthesiologists using the epidural instrument preferred to have the disposable kit pre-assembled before packaging to save valuable minutes in the operatory. Albeit a modest change, this modification required the Issuer to secure regulatory approval in Europe, which the Company has now achieved. |
||||||||||||
| MESSAGE (ENGLISH VERSION) | |||
INFORMACJE O PODMIOCIE >>>
| PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
| Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
| 2020-02-18 | Joseph D'Agostino | Chief Financial Officer | Joseph D'Agostino | ||
Źródło:Komunikaty spółek (ESPI)
